BHCM
CDMO

Brevan Howard Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Brevan Howard Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,067
Closed -$217K – 1516
2024
Q3 		$217K Sell
19,067
-23,570
-55% -$237K ﹤0.01% 969
2024
Q2 		$304K Buy
+42,637
New +$326K ﹤0.01% 770
2024
Q1 		– Sell
-17,232
Closed -$112K – 1407
2023
Q4 		$112K Buy
+17,232
New +$111K ﹤0.01% 948

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Brevan Howard Capital Management's CDMO Position: Q4 2024 in Review

Brevan Howard Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 19,067 shares — an estimated $217K sold.

Brevan Howard Capital Management first reported a position in CDMO in Q4 2023 and held it in 3 quarters. The position peaked at $304K in Q2 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Brevan Howard Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 19,067 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $217K.
  • Brevan Howard Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Brevan Howard Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $304K in Q2 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Brevan Howard Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.